There was information omitted from the Funding statement. The correct version of the Funding statement is available below: This work was supported by a service development grant from the Jewish Federation of New York and a research grant MH071651 from the National Institute of Mental Health. Dr. YIS received an investigator-initiated grant from Lundbeck Pharmaceuticals for this study and for a collaborative study (principal investigator: Dr. Joseph Zohar) entitled “Prevention of PTSD by Escitalopram.” The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.
Citation: Galatzer-Levy IR, Ankri Y, Freedman S, Israeli-Shalev Y, Roitman P, Gilad M, et al. (2013) Correction: Early PTSD Symptom Trajectories: Persistence, Recovery, and Response to Treatment: Results from the Jerusalem Trauma Outreach and Prevention Study (J-TOPS). PLoS ONE 8(8): 10.1371/annotation/0af0b6c6-ac23-4fe9-a692-f5c30a3a30b3. https://doi.org/10.1371/annotation/0af0b6c6-ac23-4fe9-a692-f5c30a3a30b3
Published: August 27, 2013
Copyright: © 2013 . This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Competing interests: No competing interests declared.